Predictive QSAR modeling: Methods and applications in drug discovery and chemical risk assessment

Handbook of Computational Chemistry

Volumn , Issue , 2012, Pages 1309-1342

  Golbraikh, Alexander ^a   Wang, Xiang Simon ^a   Zhu, Hao ^a   Tropsha, Alexander ^a  

^a UNC Hamner Institute for Drug Safety Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INDUSTRIAL CHEMICALS; MOLECULAR GRAPHICS; RISK ASSESSMENT;

CHEMICAL RISK ASSESSMENT; DRUG DISCOVERY RESEARCHES; ENVIRONMENTAL CHEMICALS; MODEL DEVELOPMENT; MOLECULAR FEATURE; PROPERTY PREDICTIONS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP MODELING; WORKFLOW APPLICATIONS;

COMPUTATIONAL CHEMISTRY;

EID: 84909614516     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-94-007-0711-5_37     Document Type: Chapter

References (152)

1. (1997). Addressing the curse of imbalanced training sets: One sided selection. San Francisco: Morgan Kaufmann.
2. Afantitis, A., Melagraki, G., Sarimveis, H., Koutentis, P. A., Markopoulos, J., & Igglessi-Markopoulou, O. (2006). A novel QSAR model for predicting induction of apoptosis by 4-aryl-4H-chromenes. Bioorganic & Medicinal Chemistry, 14, 6686.
3. Agrafiotis, D. K., Cedeno, W., & Lobanov, V. S. (2002). On the use of neural network ensembles in QSAR and QSPR. The Journal of Chemical Information and Computer Science, 42, 903.
4. Ajmani, S., Jadhav, K., & Kulkarni, S. A. (2006). Three-dimensional QSAR using the k-nearest neighbor method and its interpretation. The Journal of Chemical Information and Modeling, 46, 24.
5. Aptula, A. O., Roberts, D. W., Cronin, M. T. D., & Schultz, T. W. (2005). Chemistry-toxicity relationships for the effects of Di-and trihydroxybenzenes to Tetrahymena pyriformis. Chemical Research in Toxicology, 18, 844.
6. Austin, C. P., Brady, L. S., Insel, T. R., & Collins, F. S. (2004). NIH molecular libraries initiative. Science, 306, 1138.
7. Bailey, A. B., Chanderbhan, R., Collazo-Braier, N., Cheeseman, M. A., & Twaroski, M. L. (2005). The use of structure-activity relationship analysis in the food contact notification program. Regulatory Toxicology and Pharmacology, 42, 225.
8. Bajorath, J., Peltason, L., Wawer, M., Guha, R., Lajiness, M. S., & Van Drie, J. H. (2009). Navigating structure-activity landscapes. Drug Discovery Today, 14, 698.
9. Berk, R. A. (2008). Classification and Regression Trees (CART). Statistical learning from a regression perspective. New York: Springer.
10. Breiman, L. (1996). Bagging predictors. Machine Learning, 24, 123.
11. Breiman, L. (1998). Arcing classifiers. The Annals of Statistics, 26, 801.
12. Breiman, L. (2001). Random forests. Machine Learning, 45, 5.
13. Bures, M. G., &Martin, Y. C. (1998). Computational methods in molecular diversity and combinatorial chemistry. Current Opinion in Chemical Biology, 2, 376.
14. Burges, J. C. (1998). Tutorial on support vector machines for pattern recognition. Data Mining and Knowledge Discovery, 2, 121.
15. C5.0. (2008).
16. Carhart, R. E, Smith, D. H., & Venkataraghavan, R. (1985). Atom pairs as molecular features in structure-activity studies: Definition and applications. The Journal of Chemical Information and Computer Science, 25, 64.
17. Casey, P. J., & Seabra, M. C. (1996). Protein prenyltransferases. The Journal of Biological Chemistry, 271, 5289.
18. Cheeseman, M. A. (2005). Thresholds as a unifying theme in regulatory toxicology. Food Additives & Contaminants, 22, 900.
19. ChemAxon. (2008). http://www.chemaxon.com.
20. ChEMBL Database. (2010). http://www.ebi.ac.uk/chembldb/.
21. Chen, C., Liaw, A., & Breiman, L. (2004). Using random forest to learn imbalanced data. 666. Berkeley: Department of Statistics, University of California.
22. Cherkasov, A. (2008). An updated steroid benchmark set and its application in the discovery of novel nanomolar ligands of sex hormonebinding globulin. Journal of Medicinal Chemistry, 51, 2047.
23. Cho, S. J., Zheng, W., & Tropsha, A. (1998). Rational combinatorial library design. 2. Rational design of targeted combinatorial peptide libraries using chemical similarity probe and the inverse QSAR approaches. The Journal of Chemical Information and Computer Science, 38, 259.
24. Cox, A. D., & Der, C. J. (2002). Farnesyltransferase inhibitors: Promises and realities. Current Opinion in Pharmacology, 2, 388.
25. Crivori, P., Cruciani, G., Carrupt, P. A., & Testa, B. (2000). Predicting blood-brain barrier permeation from three-dimensional molecular structure. The Journal of Medicinal Chemistry, 43, 2204.
26. Cruciani, G., Pastor, M., & Guba, W. (2000). Vol-Surf: A new tool for the pharmacokinetic optimization of lead compounds1. The European Journal of Pharmaceutical Sciences, 11(Suppl 2), S29-S39.
27. Dash, A., Inman, W., Hoffmaster, K., Sevidal, S., Kelly, J., Obach, R.S., et al. (2009). Liver tissue engineering in the evaluation of drug safety. Expert Opinion on Drug Metabolism & Toxicology, 5, 1159.
28. de Cerqueira, L. P., Golbraikh, A., Oloff, S., Xiao, Y., & Tropsha, A. (2006). Combinatorial QSAR modeling of P-Glycoprotein substrates. The Journal of Chemical Information and Modeling, 46, 1245.
29. Discovery Studio. (2010).
30. Dix, D. J., Houck, K. A., Martin, M. T., Richard, A.M., Setzer, R. W., & Kavlock, R. J. (2007). The Tox-Cast program for prioritizing toxicity testing of environmental chemicals. Toxicological Sciences, 95, 5.
31. Dragon. (2007). http://www.talete.mi.it/help/dragon _help/index.html?IntroducingDRAGON.
32. DSSTox. (2008). http://www.epa.gov/nheerl/dsstox/About.html.
33. Durham, S. K., & Pearl, G. M. (2001). Computational methods to predict drug safety liabilities. Current Opinion in Drug Discovery & Development, 4, 110.
34. Environmental Protection Agency. (1992). Statistical training course for ground-water monitoring data analysis EPA/530-R-93-003. Washington: Office of Solid Waste.
35. Fallon, A., Spada, C., & Gallagher, D. (1997). Detection and Accommodation of Outliers in Normally Distributed Data Sets. http://ewr.cee. vt.edu/environmental/teach/smprimer/outlier/outlier.html. Accessed 25 April 2005.
36. Fechner, N., Hinselmann, G., Schmiedl, C., & Zell, A. (2008). Estimating the applicability domain of kernel-based QSPR models using classical descriptor vectors. pdf. Chemistry Central Journal, 2(Suppl.1), P2.
37. Forsby, A., & Blaauboer, B. (2007). Integration of in vitro neurotoxicity data with biokinetic modelling for the estimation of in vivo neurotoxicity. Human & Experimental Toxicology, 26, 333.
38. Fourches, D., Muratov, E., & Tropsha, A. (2010). Trust, but verify: On the importance of chemical structure curation in cheminformatics and QSAR modeling research. The Journal of Chemical Information and Modeling, 50, 1189-1204.
39. Gasteiger, J. (2006). Of molecules and humans. The Journal of Medicinal Chemistry, 49, 6429.
40. Golbraikh, A., & Tropsha, A. (2002). Predictive QSAR modeling based on diversity sampling of experimental datasets for the training and test set selection. The Journal of Computer-Aided Molecular Design, 16, 357.
41. Golbraikh, A., & Tropsha, A. (2003). QSAR modeling using chirality descriptors derived from molecular topology. The Journal of Chemical Information and Computer Science, 43, 144.
42. Golbraikh, A., Bonchev, D., & Tropsha, A. (2001). Novel chirality descriptors derived from molecular topology. The Journal of Chemical Information and Computer Science, 41, 147.
43. Golbraikh, A., Bonchev, D., & Tropsha, A. (2002). Novel ZE-isomerism descriptors derived from molecular topology and their application to QSAR analysis. The Journal of Chemical Information and Computer Science, 42, 769.
44. Golbraikh, A., Shen, M., Xiao, Z., Xiao, Y. D., Lee, K. H., & Tropsha, A. (2003). Rational selection of training and test sets for the development of validated QSAR models. The Journal of Computer-Aided Molecular Design, 17, 241.
45. Gramatica, P. (2007). Principles of QSAR models validation: Internal and external. Qsar & Combinatorial Science, 26, 694.
46. Guha, R., & Van Drie, J. H. (2008a). Structure-activity landscape index: Identifying and quantifying activity cliffs. The Journal of Chemical Information and Modeling, 48, 646.
47. Guha, R., & Van Drie, J. H. (2008b). Assessing how well a modeling protocol captures a structureactivity landscape. The Journal of Chemical Information and Modeling, 48, 1716.
48. Hoffman, B., Cho, S. J., Zheng, W., Wyrick, S., Nichols, D. E., Mailman, R. B., et al. (1999). Quantitative structure-activity relationship modeling of dopamine D(1) antagonists using comparative molecular field analysis, genetic algorithms-partial least-squares, and K nearest neighbor methods. The Journal of Medicinal Chemistry, 42, 3217.
49. Hong, H., Xie, Q., Ge, W., Qian, F., Fang, H., Shi, L., et al. (2008). Mold(2), molecular descriptors from 2D structures for chemoinformatics and toxicoinformatics. The Journal of Chemical Information and Modeling, 48, 1337.
50. Horvath, D., Bonachera, F., Solov’ev, V., Gaudin, C., & Varnek, A. (2007). Stochastic versus stepwise strategies for quantitative structure-activity relationship generation-how much effort may the mining for successful QSAR models take? The Journal of Chemical Information and Modeling, 47, 927.
51. Hsieh, J. H., Wang, X. S., Teotico, D., Golbraikh, A., & Tropsha, A. (2008). Differentiation of AmpC beta-lactamase binders vs. decoys using classification kNN QSAR modeling and application of the QSAR classifier to virtual screening. The Journal of Computer-Aided Molecular Design, 22, 593.
52. Huan, J., Bandyopadhyay, D., Prins, J., Snoeyink, J., Tropsha, A., & Wang, W. (2006). Distance-based identification of structure motifs in proteins using constrained frequent subgraph mining. Computational Systems Bioinformatics Conference, 227.
53. Inglese, J., Auld, D. S., Jadhav, A., Johnson, R. L., Simeonov, A., Yasgar, A., et al. (2006). Quantitative high-throughput screening: A titration-based approach that efficiently identifies biological activities in large chemical libraries. Proceedings of the National Academy of Sciences of the United States of America, 103, 11473.
54. Irwin, J. J., & Shoichet, B. K. (2005). ZINC-a free database of commercially available compounds for virtual screening. The Journal of Chemical Information and Modeling, 45, 177.
55. Jacobson-Kram, D., & Contrera, J. F. (2007). Genetic toxicity assessment: Employing the best science for human safety evaluation. Part I: Early screening for potential human mutagens. Toxicological Sciences, 96, 16.
56. Jaworska, J., & Nikolova-Jeliazkova, N. (2008). Review of methods to assess a QSAR Applicability Domain. http://ambit.acad.bg/nina/publications/2004/AppDomain_qsar04.ppt.
57. Jaworska, J., Nikolova-Jeliazkova, N., & Aldenberg, T. (2005). QSAR applicabilty domain estimation by projection of the training set descriptor space: A review. Alternatives to Laboratory Animals, 33, 445.
58. Johnson, S. R. (2008). The trouble with QSAR (or how I learned to stop worrying and embrace fallacy). The Journal of Chemical Information and Modeling, 48, 25.
59. Klebe, G. (1998). Comparative molecular similarity indices: CoMSI. In H. Kubinyi, G. Folkers, & Y. Martin (Eds.), 3D QSAR in drug design (pp. 87-104). Great Britain: Kluver.
60. Klopman, G., Zhu, H., Ecker, G., & Chiba, P. (2003). MCASE study of the multidrug resistance reversal activity of propafenone analogs. The Journal of Computer-Aided Molecular Design, 17, 291.
61. Kola, I., & Landis, J. (2004). Can the pharmaceutical industry reduce attrition rates? Nature Reviews Drug Discovery, 3, 711.
62. Kovatcheva, A., Golbraikh, A., Oloff, S., Feng, J., Zheng, W., & Tropsha, A. (2005). QSAR modeling of datasets with enantioselective compounds using chirality sensitive molecular descriptors. SAR and QSAR in Environmental Research, 16, 93.
63. Kubinyi, H., Hamprecht, F. A., & Mietzner, T. (1998). Three-dimensional quantitative similarityactivity relationships (3D QSiAR) from SEAL similarity matrices. The Journal of Medicinal Chemistry, 41, 2553.
64. (2000). Learning from imbalanced datasets: A comparison of various strategies. AAAI Workshop. Menlo Park: AAAI Press.
65. LigandScout. (2010).
66. Liu, T., Lin, Y., Wen, X., Jorissen, R. N., & Gilson, M. K. (2007). BindingDB: A web-accessible database of experimentally determined proteinligand binding affinities. Nucleic Acids Research, 35, D198-D201.
67. Maggiora, G. M. (2006). On outliers and activity cliffs-why QSAR often disappoints. The Journal of Medicinal Chemistry, 46, 1535.
68. Maybridge. (2005). http://www daylight com/pro ducts/databases/maybridgehtml.
69. Mayer, P., & Reichenberg, F. (2006). Can highly hydrophobic organic substances cause aquatic baseline toxicity and can they contribute to mixture toxicity? Environmental Toxicology & Chemistry, 25, 2639.
70. McGregor, M. J, & Pallai, P. V. (1997). Clustering of large databases of compounds: Using the MDL “Keys” as structural descriptors. The Journal of Chemical Information and Computer Science, 37, 443.
71. MDDR.SYMYX technologies. (2009). http://www.mdl.com/products / knowledge / drug_data_re port/index.jsp.
72. Medina-Franco, J. L., Golbraikh, A., Oloff, S., Castillo, R., & Tropsha, A. (2005). Quantitative structure-activity relationship analysis of pyridinone HIV-1 reverse transcriptase inhibitors using the k nearest neighbor method and QSARbased databasemining. The Journal of Computer-Aided Molecular Design, 19, 229.
73. Molconn-Z. (2007). http://www.edusoft- lc.com/.
74. Molecular Operating Environment (MOE). (2008). http://www.chemcomp.com/.
75. Muster, W., Breidenbach, A., Fischer, H., Kirchner, S., Muller, L., & Pahler, A. (2008). Computational toxicology in drug development. Drug Discovery Today, 13, 303.
76. nci. (2007). http://dtp.nci.nih.gov/docs/3d_databa se/structural_information/smiles_strings.html.
77. Netzeva, T. I., Gallegos, S. A., & Worth, A. P. (2006). Comparison of the applicability domain of a quantitative structure-activity relationship for estrogenicity with a large chemical inventory. Environmental Toxicology & Chemistry, 25, 1223.
78. Netzeva, T. I., & Schultz, T. W. (2005). QSARs for the aquatic toxicity of aromatic aldehydes from Tetrahymena data. Chemosphere, 61, 1632.
79. (1996). Neural networks in QSAR and drug design. San Diego: Academic.
80. Neural Networks. (2010). http://www.learnartificialneuralnetworks.com/.
81. Nikolova-Jeliazkova, N., & Jaworska, J. (2005). An approach to determining applicability domains for QSAR group contribution models: An analysis of SRC KOWWIN. Alternatives to Laboratory Animals, 33, 461.
82. Olah, M., Rad, R., Ostopovici, L., Bora, A., Hadaruga, N., Hadaruga, D., et al. (2007). WOMBAT and WOMBAT-PK: Bioactivity databases for lead and drug discovery. In S. L. Schreiber, T. M. Kapoor, & G. Weiss (Eds.), Chemical biology: From small molecules to systems biology and drug design (pp. 760-786). Weinheim: Wiley-VCH.
83. Oloff, S., Mailman, R. B., & Tropsha, A. (2005). Application of validated QSAR models of D1 dopaminergic antagonists for database mining. The Journal of Medicinal Chemistry, 48, 7322.
84. (2010). OpenBabel: The OpenSource Chemistry Toolbox. Openbabel.org. 2-1-2010.
85. Oprea, T., & Tropsha, A. (2006). Target, chemical and bioactivity databases - integration is key. Drug Discovery Today, 3, 357-365.
86. Organisation for Economic and Co-operation Development. (2008). OECD Quantitative Structure-Activity Relationships [(Q)SARs] Project. http:// www.oecd.org/document/23/0,3343, en_2649_3 4365_33957015_1_1_1_1,00.html.
87. Park, M. V., Lankveld, D. P., van, L. H., & de Jong, W. H. (2009). The status of in vitro toxicity studies in the risk assessment of nanomaterials. Nanomedicine (Lond), 4, 669.
88. Pastor, M., Cruciani, G., McLay, I., Pickett, S., & Clementi, S. (2000). GRid-INdependent descriptors (GRIND): A novel class of alignment-independent three-dimensional molecular descriptors. The Journal of Medicinal Chemistry, 43, 3233.
89. PDSP. (2010). PDSP. http://pdsp.med.unc.edu.
90. Peterson, Y. K., Kelly, P., Weinbaum, C. A., & Casey, P. J. (2006). A novel protein geranylgeranyltransferase-I inhibitor with high potency, selectivity, and cellular activity. The Journal of Biological Chemistry, 281, 12445.
91. Peterson, Y. K., Wang, X. S., Casey, P. J., &Tropsha, A. (2009). Discovery of geranylgeranyltransferase-I inhibitors with novel scaffolds by the means of quantitative structure-activity relationship modeling, virtual screening, and experimental validation. The Journal of Medicinal Chemistry, 52, 4210.
92. Piersma, A. H., Janer, G., Wolterink, G., Bessems, J. G., Hakkert, B. C., & Slob, W. (2008). Quantitative extrapolation of in vitro whole embryo culture embryotoxicity data to developmental toxicity in vivo using the benchmark dose approach. Toxicological Sciences, 101, 91.
93. PubChem. (2010). http://pubchem.ncbi.nlm.nih. gov/.
94. Quinlan, J. R. (1993). C4.5: Programs for machine learning. San Mateo: Morgan Kaufmann.
95. Random Forests. (2001).
96. Riley, R. J., & Kenna, J. G. (2004). Cellular models for ADMET predictions and evaluation of drug-drug interactions. Current Opinion in Drug Discovery & Development, 7, 86.
97. Robinson, D. D., Winn, P. J., Lyne, P. D., & Richards, W. G. (1999). Self-organizing molecular field analysis: A tool for structure-activity studies. The Journal of Medicinal Chemistry, 42, 573.
98. Saliner, A. G., Netzeva, T. I., & Worth, A. P. (2006). Prediction of estrogenicity: Validation of a classification model. SAR and QSAR in Environmental Research, 17, 195.
99. Salt, D. V., Yildiz, N., Livingstone, D. J., & Tinsley, C. J. (2006). The use of artificial neural networks in QSAR. Pestcide Science, 36, 161.
100. Schirmer, K., Tanneberger, K., Kramer, N. I., Volker, D., Scholz, S., Hafner, C., et al. (2008). Developing a list of reference chemicals for testing alternatives to whole fish toxicity tests. Aquatic Toxicology, 90, 128.
101. Schrodinger Software. (2010).
102. Schultz, T. W. (1999). Structure-toxicity relationships for benzenes evaluated with Tetrahymena pyriformis. Chemical Research in Toxicology, 12, 1262.
103. Schultz, T. W., & Netzeva, T. I. (2004). Development and evaluation of QSARs for ecotoxic endpoints: The benzene response-surface model for Tetrahymena toxicity. In M. T. D. Cronin & D. J. Livingstone (Eds.), Modeling environmental fate and toxicity (pp. 265-284). Boca Raton: CRC Press.
104. Schultz, T. W., Cronin, M. T., Netzeva, T. I., & Aptula, A. O. (2002). Structure-toxicity relationships for aliphatic chemicals evaluated with Tetrahymena pyriformis. Chemical Research in Toxicology, 15, 1602.
105. Schultz, T. W., Hewitt, M., Netzeva, T. I., & Cronin, M. T. D. (2007). Assessing applicability domains of toxicological QSARs: Definition, confidence in predicted values, and the role of mechanisms of action. QSAR & Combinatorial Science, 26, 238.
106. Schultz, T. W., Netzeva, T. I., & Cronin, M. T. (2003). Selection of data sets for QSARs: Analyses of Tetrahymena toxicity from aromatic compounds. SAR and QSAR in Environmental Research, 14, 59.
107. Schultz, T. W., Netzeva, T. I., Roberts, D. W., & Cronin, M. T. (2005a). Structure-toxicity relationships for the effects to Tetrahymena pyriformis of aliphatic, carbonyl-containing, alpha, beta-unsaturated chemicals. Chemical Research in Toxicology, 18, 330.
108. Schultz, T. W., Yarbrough, J. W., & Woldemeskel, M. (2005b). Toxicity to Tetrahymena and abiotic thiol reactivity of aromatic isothiocyanates. Cell Biology and Toxicology, 21, 181.
109. Schultz, T. W., Sinks, G. D., & Miller, L. A. (2001). Population growth impairment of sulfur-containing compounds to Tetrahymena pyriformis. Environmental Toxicology, 16, 543.
110. Sebti, S. M., & Hamilton, A. D. (2000). Farnesyltransferase and geranylgeranyltransferase I inhibitors in cancer therapy: Important mechanistic and bench to bedside issues. Expert Opinion on Investigational Drugs, 9, 2767.
111. Sedykh, A., Zhu, H., Tang, H., Zhang, L., Rusyn, I., Richard, A., et al. The use of dose-response qHTS data as biological descriptors improves the prediction accuracy of QSAR models of acute rat toxicity. Environmental Health Perspect, In press.
112. Shen, M., Beguin, C., Golbraikh, A., Stables, J. P., Kohn, H., & Tropsha, A. (2004). Application of predictive QSAR models to database mining: Identification and experimental validation of novel anticonvulsant compounds. Journal of Medicinal Chemistry, 47, 2356.
113. Shen, M., LeTiran, A., Xiao, Y., Golbraikh, A., Kohn, H., &Tropsha, A. (2002). Quantitative structureactivity relationship analysis of functionalized amino acid anticonvulsant agents using k nearest neighbor and simulated annealing PLS methods. The Journal of Medicinal Chemistry, 45, 2811.
114. Sisay, M. T., Peltason, L., Bajorath, J. (2009). Structural interpretation of activity cliffs revealed by systematic analysis of structure-activity relationships in analog series. The Journal of Chemical Information and Modeling, 49, 2179.
115. Sjostrom, M., Kolman, A., Clemedson, C., & Clothier, R. (2008). Estimation of human blood LC50 values for use in modeling of in vitro-in vivo data of the ACuteTox project. Toxicology In Vitro, 22, 1405.
116. Smola, A. J., & Schoelkopf, B. A. (2004). Tutorial on support vector regression. Tuebingen: Max Planck Society - eDocument Server (Germany).
117. Snyder, R. D. (2009). An update on the genotoxicity and carcinogenicity of marketed pharmaceuticals with reference to in silico predictivity. Environmental and Molecular Mutagenesis, 50, 435.
118. Stoner, C. L., Gifford, E., Stankovic, C., Lepsy, C. S., Brodfuehrer, J., Prasad, J. V. N. V., et al. (2004). Implementation of an ADME enabling selection and visualization tool for drug discovery. Journal of Pharmaceutical Sciences, 93, 1131.
119. Stouch, T. R., Kenyon, J. R., Johnson, S. R., Chen, X. Q., Doweyko, A., & Li, Y. (2003). In silico ADME/Tox: why models fail. The Journal of Computer-Aided Molecular Design, 17, 83.
120. Tetko, I. V., Bruneau, P., Mewes, H.W., Rohrer, D. C., & Poda, G. I. (2006). Can we estimate the accuracy of ADME-Tox predictions? Drug Discovery Today, 11, 700.
121. The Foundations of Cost-sensitive Learning. (2001).
122. Thomas, C. J., Auld, D. S., Huang, R., Huang, W., Jadhav, A., Johnson, R. L., et al. (2009). The pilot phase of the NIH chemical genomics center. Current Topics in Medicinal Chemistry, 9, 1181.
123. Todeschini, R., & Consonni, V. (2000). Handbook of molecular descriptors. Weinheim: Wiley-VCH.
124. Tripos. (2010). Sybyl-X 1.0.
125. Tropsha, A. (2005). Application of predictive QSAR models to database mining. In T. Oprea (Eds.), Cheminformatics in drug discovery (pp. 437-455). Wiley-VCH.
126. Tropsha, A., & Golbraikh, A. (2007). Predictive QSAR modeling workflow, model applicability domains, and virtual screening. Current Pharmaceutical Design, 13, 3494.
127. Tropsha, A., & Golbraikh, A. (2010). Predictive quantitative structure-activity relationships modeling: Development and validation of QSAR models. In J.-L. Faulon & A. Bender (Eds.), Handbook of chemoinformatics algorithms. The Netherlands: Leiden University, Chapman and Hall/CRC.
128. Tropsha, A., & Golbraikh, A. (2010). Predictive quantitative structure-activity relationships modeling. Data Preparation and the General Modeling Workflow. In J.-L. Faulon & A. Bender (Eds.), Handbook of chemoinformatics algorithms (pp. 175-214). The Netherland: Leiden University, Chapman and Hall/CRC.
129. Tropsha, A., & Zheng, W. (2001). Identification of the descriptor pharmacophores using variable selection QSAR: Applications to database mining. Current Pharmaceutical Design, 7, 599.
130. Valerio, L., Jr. (2008). Tools for evidence-based toxicology: Computational-based strategies as a viable modality for decision support in chemical safety evaluation and risk assessment. Human & Experimental Toxicology, 27, 757.
131. Valerio, L. G., Jr. (2009). In silico toxicology for the pharmaceutical sciences. Toxicology and Applied Pharmacology, 241, 356.
132. Vapnik, V. (2000). Nature of statistical learning theory. New York: Springer.
133. Votano, J. R., Parham, M., Hall, L. H., Kier, L. B., Oloff, S., Tropsha, A., et al. (2004). Three new consensus QSAR models for the prediction of Ames genotoxicity. Mutagenesis, 19, 365.
134. Waller, C. L. (2004). A comparative QSAR study using CoMFA, HQSAR, and FRED/SKEYS paradigms for estrogen receptor binding affinities of structurally diverse compounds. The Journal of Chemical Information and Computer Science, 44, 758.
135. Winter-Vann, A. M, & Casey, P. J. (2005). Postprenylation-processing enzymes as new targets in oncogenesis. Nature Reviews Cancer, 5, 405.
136. Xia, M., Huang, R., Witt, K. L., Southall, N., Fostel, J., Cho, M. H., et al. (2008). Compound cytotoxicity profiling using quantitative high-throughput screening. Environmental Health Perspect, 116, 284.
137. Yang, C., Richard, A. M., & Cross, K. P. (2006). The art of data mining the minefields of toxicity databases to link chemistry to biology. Current Computer-Aided Drug Design, 2, 135.
138. Yang, C., Valerio, L. G., Jr., & Arvidson, K. B. (2009). Computational toxicology approaches at the US food and drug administration. Alternatives to Laboratory Animals, 37, 523.
139. Yen, S.-J., Lee, Y.-S. (2006). Under-sampling approaches for improving prediction of the minority class in an imbalanced dataset. Lecture Notes in Control and Information Sciences, 344, 731.
140. Zhang, F. L., & Casey, P. J. (1996). Protein prenylation: Molecular mechanisms and functional consequences. Annual Review of Biochemistry, 65, 241.
141. Zhang, S., Wei, L., Bastow, K., Zheng, W., Brossi, A., Lee, K. H., et al. (2007). Antitumor agents 252. Application of validated QSAR models to database mining: Discovery of novel tylophorine derivatives as potential anticancer agents. Journal of Computer-Aided Molecular Design, 21, 97.
142. Zhang, L., Zhu, H., Oprea, T. I., Golbraikh, A., & Tropsha, A. (2008). QSAR modeling of the blood-brain barrier permeability for diverse organic compounds. Pharmaceutical Research, 25, 1902.
143. Zheng, W., & Tropsha, A. (2000). Novel variable selection quantitative structure-property relationship approach based on the k-nearestneighbor principle. The Journal of Chemical Information and Computer Science, 40, 185.
144. Zhou, Z. H., & Liu, X.-Y. (2006). Training costsensitive neural networks with methods addressing the class imbalance problem. IEEE Transactions on Knowledge and Data Engineering, 18, 63.
145. Zhu, H., Rusyn, I., Richard, A. M., & Tropsha, A. (2008). Use of cell viability assay data improves the prediction accuracy of conventional quantitative structure-activity relationship models of animal carcinogenicity. Environmental Health Perspect, 116, 506.
146. Zhu, H., Tropsha, A., Fourches, D., Varnek, A., Papa, E., Gramatica, P., et al. (2008). Combinatorial QSAR modeling of chemical toxicants tested against tetrahymena pyriformis. Journal of Chemical Information and Modeling, 48, 766.
147. Zhu, H., Tropsha, A., Fourches, D., Varnek, A., Papa, E., Gramatica, P., et al. (2008). Combinatorial QSAR modeling of chemical toxicants tested against tetrahymena pyriformis. The Journal of Chemical Information and Modeling.
148. Zhu, H., Ye, L., Golbraikh, A., & Tropsha, A. (2009). QSAR studies of chemical aquatic acute toxicity using k Nearest Neighbor (kNN) Methodology.
149. Zhu, H., Ye, L., Richard, A., Golbraikh, A., Wright, F. A., Rusyn, I., et al. (2009). A novel two-step hierarchical quantitative structure-activity relationship modeling work flow for predicting acute toxicity of chemicals in rodents. Environmental Health Perspect, 117, 1257.
150. Zupan, J., & Gasteiger, J. (1999). Neural networks in chemistry and drug design. Weinheim: Wiley-VCH.
151. Zvinavashe, E., Murk, A. J., & Rietjens, I. M. (2008). Promises and pitfalls of quantitative structureactivity relationship approaches for predicting metabolism and toxicity. Chemical Research in Toxicology.
152. Zvinavashe, E., Murk, A. J., & Rietjens, I. M. (2009). On the number of EINECS compounds that can be covered by (Q)SAR models for acute toxicity. Toxicology Letters, 184, 67.